Cryptococcal antigen prevalence in HIV-infected Tanzanians: a cross-sectional study and evaluation of a point-of-care lateral flow assay.

Objectives: Cryptococcal antigen (CRAG) screening at antiretroviral therapy (ART) initiation and pre-emptive antifungal treatment for those testing positive could prevent many cases of cryptococcal meningitis (CM). To investigate whether CRAG screening would be feasible in Tanzania, we conducted a c...

Full description

Bibliographic Details
Published in:Tropical Medicine & International Health Vol. 18; no. 9; pp. 1075 - 1080
Main Authors: Rugemalila, Joan, Maro, Venance P, Kapanda, Gibson, Ndaro, Arnold J, Jarvis, Joseph N
Format: research Journal Article
Published: Wiley-Blackwell Sep2013
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104210641&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 104210641
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        13602276
        1YC
      jtl: Tropical Medicine & International Health
      issn: 13602276
      maglogo: Y
    pubinfo:
      dt: Sep2013
      vid: 18
      iid: 9
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        104210641
        NLM23937699
        2012225896
        10.1111/tmi.12157
        NLM23937699
        104210641
      ppf: 1075
      ppct: 5
      formats:
      tig:
        atl: Cryptococcal antigen prevalence in HIV-infected Tanzanians: a cross-sectional study and evaluation of a point-of-care lateral flow assay.
      aug:
        au:
          Rugemalila, Joan
          Maro, Venance P
          Kapanda, Gibson
          Ndaro, Arnold J
          Jarvis, Joseph N
        affil: Department of Medicine, Kilimanjaro Christian Medical University College, Moshi, Tanzania.
      sug:
        subj:
          AIDS-Related Opportunistic Infections Epidemiology
          Antifungal Agents Therapeutic Use
          Antigens, Fungal Blood
          Cryptococcus Immunology
          Meningitis, Cryptococcal Epidemiology
          AIDS-Related Opportunistic Infections Blood
          AIDS-Related Opportunistic Infections Diagnosis
          AIDS-Related Opportunistic Infections Drug Therapy
          Adult
          Anti-HIV Agents Therapeutic Use
          CD4 Lymphocyte Count
          Cross Sectional Studies
          Cryptococcus
          Female
          Human
          Male
          Meningitis, Cryptococcal Blood
          Meningitis, Cryptococcal Diagnosis
          Meningitis, Cryptococcal Drug Therapy
          Middle Age
          Clinical Information Systems
          Epidemiological Research
          Tanzania
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Female
          Male
      ab: Objectives: Cryptococcal antigen (CRAG) screening at antiretroviral therapy (ART) initiation and pre-emptive antifungal treatment for those testing positive could prevent many cases of cryptococcal meningitis (CM). To investigate whether CRAG screening would be feasible in Tanzania, we conducted a cross-sectional study measuring CRAG prevalence in ART clinic patients and comparing the novel lateral flow assay (LFA) with the cryptococcal latex agglutination (LA) test.Methods: Consecutive HIV-infected outpatients with CD4 counts <200 cells/µL, who were ART naive or had been on ART for <6 months, were screened for CRAG using the LA and LFA kits. For further assay validation, HIV-infected inpatients with suspected cryptococcal disease were also tested using the LA and LFA kits.Results: Cryptococcal antigen was detected in seven of 218 ART clinic attendees (3%). Six patients (5%) with CD4 cell counts ≤100 cells/µL (n = 124) were CRAG-positive. Agreement between the LA and LFA test in the 218 outpatients was 100%. Another 101 inpatients were tested for CRAG, of whom 56 (55%) were CRAG-positive on both the LA and LFA tests. One patient was positive using the LFA test but negative on the LA test. The overall agreement between the two assays was 99.7%, kappa coefficient 0.99 (standard error 0.06, P < 0.001).Conclusions: Five percentage of ART clinic patients with CD4 cell counts ≤100 cells/µL in northern Tanzania had asymptomatic cryptococcal antigenaemia, suggesting that CRAG screening would be worthwhile in the Tanzanian ART programme. The LFA is a reliable, cheap and practical alternative to LA for detection of CRAG.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N